These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 11280134)

  • 21. ACE inhibitors and risk of hypoglycemia in people with diabetes.
    Chaturvedi N; Fuller JH
    Diabetes Care; 1998 Mar; 21(3):470-2. PubMed ID: 9540046
    [No Abstract]   [Full Text] [Related]  

  • 22. Risk of severe hypoglycemia in diabetes patients taking ACE inhibitors.
    Strachan MW; Frier BM
    Diabetes Care; 1998 Mar; 21(3):470; author reply 471-2. PubMed ID: 9540045
    [No Abstract]   [Full Text] [Related]  

  • 23. [Adrenergic beta-blocker medication, formally contraindicated in all forms of diabetes mellitus?].
    Tacu V; Blum M; Tudor G; Mandric E
    Rev Med Chir Soc Med Nat Iasi; 1984; 88(3):535-9. PubMed ID: 6152746
    [No Abstract]   [Full Text] [Related]  

  • 24. Follow-up of intensive glucose control in type 2 diabetes.
    Cruickshank JM
    N Engl J Med; 2009 Jan; 360(4):417-8; author reply 418. PubMed ID: 19172673
    [No Abstract]   [Full Text] [Related]  

  • 25. [Is it necessary to systematically treat diabetics with ACE inhibitors?].
    Marre M; Collet C; Stevenin C
    Journ Annu Diabetol Hotel Dieu; 2001; ():185-7. PubMed ID: 11565461
    [No Abstract]   [Full Text] [Related]  

  • 26. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.
    UK Prospective Diabetes Study Group
    BMJ; 1998 Sep; 317(7160):703-13. PubMed ID: 9732337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular therapies and risk for development of diabetes.
    Pepine CJ; Cooper-Dehoff RM
    J Am Coll Cardiol; 2004 Aug; 44(3):509-12. PubMed ID: 15358012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Left ventricular hypertrophy. Recent aspects of diagnosis and therapy].
    Schmieder RE; Schneider MP
    MMW Fortschr Med; 2002 Oct; 144(42):45-6. PubMed ID: 12533997
    [No Abstract]   [Full Text] [Related]  

  • 29. [Are the newer antihypertensive agents better and more effective than diuretics?].
    Landmark K
    Tidsskr Nor Laegeforen; 2001 Feb; 121(6):701-5. PubMed ID: 11293353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. UK Prospective Diabetes Study Group.
    UK Prospective Diabetes Study Group
    BMJ; 1998 Sep; 317(7160):720-6. PubMed ID: 9732339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Old or new antihypertensives--which are better?].
    Schrader J; Kulschewski A
    MMW Fortschr Med; 2005 Mar; 147(13):36-7, 39-40. PubMed ID: 15832760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of high blood pressure in diabetes mellitus: lessons from The ADA Recommendation.
    Waspadji S
    Acta Med Indones; 2004; 36(1):31-5. PubMed ID: 15673934
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-term safety of antihypertensive therapy.
    Grossman E; Messerli FH
    Prog Cardiovasc Dis; 2006; 49(1):16-25. PubMed ID: 16867847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The management of the diabetic patient with prior cardiovascular events.
    Fonarow GC
    Rev Cardiovasc Med; 2003; 4 Suppl 6():S38-49. PubMed ID: 14668702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood pressure reduction is not the only determinant of outcome.
    Sever PS; Poulter NR; Elliott WJ; Jonsson MC; Black HR; Sever PS; Poulter NR; Elliott WJ; Jonsson MC; Black HR
    Circulation; 2006 Jun; 113(23):2754-72; discussion 2773-4. PubMed ID: 16769926
    [No Abstract]   [Full Text] [Related]  

  • 36. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
    Califf RM; Lokhnygina Y; Velazquez EJ; McMurray JJ; Leimberger JD; Lewis EF; Diaz R; Murin J; Pfeffer MA
    Am J Cardiol; 2009 Jul; 104(2):151-7. PubMed ID: 19576338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selecting antihypertensive medication in patients with essential hypertension in Malaysia.
    Ong HT; Rozina G
    Med J Malaysia; 2009 Mar; 64(1):3-11. PubMed ID: 19852313
    [No Abstract]   [Full Text] [Related]  

  • 38. Trends in antihypertensive and lipid-lowering therapy in subjects with type II diabetes: clinical effectiveness or clinical discretion?
    Gulliford MC; Charlton J; Latinovic R
    J Hum Hypertens; 2005 Feb; 19(2):111-7. PubMed ID: 15361893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Renin-angiotensin system blockade reduces cardiovascular mortality and morbidity attributable to arterial hypertension by primary and secondary prevention. The end of the road?].
    Coca A; Ruilope LM
    Med Clin (Barc); 2000 Jul; 115(5):178-80. PubMed ID: 10996874
    [No Abstract]   [Full Text] [Related]  

  • 40. [Type 2 diabetes. Routine ACE inhibitors?].
    Hönl SB
    Med Monatsschr Pharm; 2008 Apr; 31(4):149-50. PubMed ID: 18497249
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.